FDA Warns Canadian Drugmaker Over GMPs

Drug Industry Daily
A A
The FDA warned a Canadian drugmaker over GMP violations that rendered its anti-aging products adulterated.

To View This Article:

Login

Subscribe To Drug Industry Daily